Penumbra
PEN
#1848
Rank
$8.91 B
Marketcap
$232.39
Share price
1.25%
Change (1 day)
16.96%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Revenue for Penumbra (PEN)

Revenue in 2024 (TTM): $1.16 Billion USD

According to Penumbra's latest financial reports the company's current revenue (TTM ) is $1.16 Billion USD. In 2023 the company made a revenue of $1.05 Billion USD an increase over the revenue in the year 2022 that were of $0.84 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Penumbra from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $1.16 B9.94%
2023 $1.05 B24.95%
2022 $0.84 B13.32%
2021 $0.74 B33.4%
2020 $0.56 B2.38%
2019 $0.54 B23.03%
2018 $0.44 B33.31%
2017 $0.33 B26.75%
2016 $0.26 B41.5%
2015 $0.18 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$0.57 B-50.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.32 B 13.93%๐Ÿ‡บ๐Ÿ‡ธ USA